Perceptive Advisors as of June 30, 2012
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 66 positions in its portfolio as reported in the June 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Questcor Pharmaceuticals | 7.4 | $29M | 550k | 53.24 | |
| Neurocrine Biosciences (NBIX) | 7.4 | $29M | 3.7M | 7.89 | |
| Infinity Pharmaceuticals (INFIQ) | 7.3 | $29M | 2.1M | 13.56 | |
| Regeneron Pharmaceuticals (REGN) | 7.2 | $29M | 250k | 114.22 | |
| Repros Therapeutics | 6.5 | $26M | 2.9M | 9.08 | |
| Aegerion Pharmaceuticals | 6.2 | $25M | 1.7M | 14.84 | |
| Capital Senior Living Corporation | 4.2 | $17M | 1.6M | 10.60 | |
| Medivation | 4.1 | $16M | 176k | 91.40 | |
| Mylan | 3.9 | $16M | 730k | 21.37 | |
| Neptune Technologies Bioreso | 3.5 | $14M | 2.9M | 4.74 | |
| Ariad Pharmaceuticals | 3.5 | $14M | 795k | 17.21 | |
| Illumina (ILMN) | 3.0 | $12M | 295k | 40.39 | |
| Onyx Pharmaceuticals | 2.7 | $11M | 160k | 66.45 | |
| Endo Pharmaceuticals | 2.7 | $11M | 343k | 30.98 | |
| Arena Pharmaceuticals | 2.3 | $9.1M | 915k | 9.98 | |
| NPS Pharmaceuticals | 2.2 | $8.8M | 1.0M | 8.61 | |
| United Therapeutics Corporation (UTHR) | 2.1 | $8.4M | 170k | 49.38 | |
| Medicis Pharmaceutical Corporation | 1.7 | $6.8M | 200k | 34.15 | |
| Celgene Corporation | 1.4 | $5.8M | 90k | 64.16 | |
| Seattle Genetics | 1.3 | $5.1M | 200k | 25.39 | |
| PROLOR Biotech | 1.2 | $4.9M | 970k | 5.01 | |
| Valeant Pharmaceuticals Int | 1.1 | $4.5M | 100k | 44.89 | |
| Conceptus | 1.1 | $4.2M | 214k | 19.82 | |
| Synta Pharmaceuticals | 1.0 | $4.1M | 742k | 5.47 | |
| DepoMed | 0.9 | $3.7M | 650k | 5.69 | |
| Sunrise Senior Living | 0.9 | $3.7M | 503k | 7.29 | |
| Amgen | 0.9 | $3.6M | 50k | 72.92 | |
| Protalix BioTherapeutics | 0.8 | $3.3M | 571k | 5.73 | |
| Alnylam Pharmaceuticals (ALNY) | 0.7 | $2.8M | 237k | 11.65 | |
| Clovis Oncology | 0.7 | $2.7M | 126k | 21.68 | |
| MAKO Surgical | 0.7 | $2.6M | 100k | 25.61 | |
| Cutera (CUTR) | 0.6 | $2.4M | 338k | 7.19 | |
| Athersys | 0.6 | $2.3M | 1.5M | 1.61 | |
| Affymax (AFFY) | 0.6 | $2.3M | 180k | 12.88 | |
| Transgenomic | 0.6 | $2.2M | 2.0M | 1.11 | |
| Uroplasty | 0.6 | $2.2M | 477k | 4.59 | |
| EXACT Sciences Corporation (EXAS) | 0.5 | $2.1M | 200k | 10.72 | |
| BioMarin Pharmaceutical (BMRN) | 0.5 | $2.0M | 50k | 39.58 | |
| Dyax Corp | 0.5 | $2.0M | 925k | 2.13 | |
| AVI BioPharma ComStk Usd0.0001 | 0.5 | $1.8M | 2.9M | 0.63 | |
| Syneron Medical Ltd ord | 0.4 | $1.8M | 169k | 10.38 | |
| Neostem (NBS) | 0.4 | $1.6M | 3.3M | 0.49 | |
| XOMA CORP Common equity shares | 0.4 | $1.6M | 530k | 2.98 | |
| Optimer Pharmaceuticals | 0.4 | $1.5M | 100k | 15.46 | |
| Biogen Idec (BIIB) | 0.4 | $1.4M | 10k | 144.40 | |
| Warner Chilcott Plc - | 0.3 | $1.3M | 75k | 17.93 | |
| Synergy Pharmaceuticals | 0.3 | $1.2M | 250k | 4.75 | |
| Pharmacyclics | 0.3 | $1.1M | 20k | 54.60 | |
| Lexicon Pharmaceuticals | 0.2 | $895k | 398k | 2.25 | |
| Ligand Pharmaceuticals In (LGND) | 0.2 | $783k | 46k | 16.94 | |
| Sagent Pharmaceuticals | 0.2 | $685k | 38k | 18.07 | |
| Immunomedics | 0.2 | $651k | 183k | 3.56 | |
| Angeion Corporation | 0.1 | $584k | 102k | 5.71 | |
| Idenix Pharmaceuticals | 0.1 | $514k | 50k | 10.28 | |
| Trinity Biotech | 0.1 | $444k | 37k | 12.01 | |
| Array BioPharma | 0.1 | $347k | 100k | 3.47 | |
| Raptor Pharmaceutical | 0.1 | $349k | 63k | 5.58 | |
| Chemocentryx | 0.1 | $309k | 21k | 15.00 | |
| BioMimetic Therapeutics | 0.1 | $263k | 100k | 2.63 | |
| Jazz Pharmaceuticals (JAZZ) | 0.1 | $225k | 5.0k | 45.00 | |
| Celsion Corporation | 0.1 | $192k | 63k | 3.07 | |
| Senesco Technologies | 0.0 | $141k | 670k | 0.21 | |
| Anthera Pharmaceuticals | 0.0 | $41k | 60k | 0.68 | |
| Genvec | 0.0 | $33k | 14k | 2.36 | |
| Trius Therapeutics | 0.0 | $999.250000 | 175.00 | 5.71 | |
| Combimatrix Corporation *w exp 05/01/201 | 0.0 | $5.0k | 50k | 0.10 |
